Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 330
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Viral Hepat ; 24(2): 141-147, 2017 02.
Article in English | MEDLINE | ID: mdl-27766731

ABSTRACT

We compared the viral suppressive efficacy of tenofovir disoproxil fumarate (TDF) mono-rescue therapy (TDF group) and TDF plus entecavir (ETV) combination-rescue therapy (TDF + ETV group) in chronic hepatitis B (CHB) patients with lamivudine resistance and entecavir resistance. One hundred and thirty-three CHB patients with lamivudine and entecavir resistance were investigated. Ninety-six patients were treated with TDF and 37 with TDF + ETV for at least 6 months. We compared the virologic response rate (HBV DNA level <20 IU/mL) between the two groups and identified the predictive factors of treatment outcome. There were no significant differences between the two groups in demographic characteristics. Up to 24 months [median: 18 (range 6-24) months], 85.4% and 89.2% of the TDF group and TDF + ETV group, respectively, achieved a virologic response (P=.068). Only the HBV DNA level at baseline was significantly associated with a virologic response in the multivariate analysis. In a subanalysis of patients with HBV DNA levels ≥4 log (IU/mL) at baseline, a higher proportion of patients in the TDF + ETV group than the TDF group achieved a virologic response (92.9% vs 68.3%; P<.001), while 90% of patients with HBV DNA (IU/mL) levels <4 log in all both TDF and TDF + ETV groups achieved a virologic response. TDF mono-rescue therapy is a reasonable option in patients with lamivudine resistance and entecavir resistance. However, the combination strategy should be considered in patients with high baseline HBV DNA levels.


Subject(s)
Antiviral Agents/therapeutic use , Drug Resistance, Viral , Guanine/analogs & derivatives , Hepatitis B virus/drug effects , Hepatitis B, Chronic/drug therapy , Tenofovir/therapeutic use , Adult , Aged , Aged, 80 and over , Antiviral Agents/pharmacology , DNA, Viral/blood , Female , Guanine/pharmacology , Guanine/therapeutic use , Hepatitis B virus/isolation & purification , Hepatitis B, Chronic/virology , Humans , Lamivudine/pharmacology , Male , Middle Aged , Tenofovir/pharmacology , Treatment Outcome , Viral Load , Young Adult
2.
Scand J Immunol ; 83(6): 409-17, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26900758

ABSTRACT

Psoriasis is a chronic inflammatory immune-mediated autoimmune skin disorder. The histamine H4 receptor (H4R) agonist 4-methylhistamine (4-MH) plays an important role in immunomodulation of inflammatory responses associated with allergic inflammatory diseases. In this study, we investigated the effects of H4R agonist 4-MH on the development of imiquimod (IMQ)-induced psoriasis-like skin inflammation in mice and explored the immunoregulatory mechanism involved. The total clinical severity scores were significantly ameliorated by treatment with 4-MH (20 mg/kg) and 4-MH (40 mg/kg). Histological analysis of the skin revealed that 4-MH (20 mg/kg) and 4-MH (40 mg/kg) significantly attenuated the psoriatic phenotypes, including epidermal hyperplasis, hyperkeratosis and lymphocytes infiltration. Treatment with 4-MH (20 mg/kg) and 4-MH (40 mg/kg) led to reductions in the levels of Th1 cytokines (TNF-α, IFN-α, and IL-27) in the serum and dorsal skin, whereas Th17 cytokines levels (IL-17A and IL-23) did not change in response to treatment with 4-MH (20 mg/kg) and 4-MH (40 mg/kg). Furthermore, the number of CD4(+) CD25(+) FoxP3(+) regulatory T (Treg) cells was significantly increased by treatment with 4-MH (40 mg/kg). Taken together, these results imply that H4R agonist 4-MH might be an effective immunomodulatory approach for treatment of patients with psoriasis and the effects may be related to inhibited epidermal alteration, selectively reduced Th1 pro-inflammatory cytokines, and recruited CD4(+) CD25(+) FoxP3(+) Treg cells.


Subject(s)
Inflammation/drug therapy , Methylhistamines/therapeutic use , Psoriasis/drug therapy , Skin/drug effects , T-Lymphocytes, Regulatory/drug effects , Th1 Cells/drug effects , Aminoquinolines/administration & dosage , Animals , Cell Movement/drug effects , Cytokines/metabolism , Disease Models, Animal , Female , Forkhead Transcription Factors/metabolism , Humans , Imiquimod , Inflammation/chemically induced , Interleukin-2 Receptor alpha Subunit/metabolism , Methylhistamines/pharmacology , Mice , Mice, Inbred C57BL , Psoriasis/chemically induced , Receptors, G-Protein-Coupled/agonists , Receptors, Histamine , Receptors, Histamine H4 , Skin/immunology , Skin/pathology , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology
3.
Int J Sports Med ; 36(13): e24-e30, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26528942

ABSTRACT

Little is known regarding whether adiponectin receptors mediate high-intensity interval training (HIT)-induced improvement of insulin resistance associated with obesity. This study investigated the effect of HIT on whole body insulin resistance in high-fat diet-induced obese mice. 5-week-old male mice (N=30) were randomly assigned to standard chow (SC) (n=10) or HFD (n=20) for 23 weeks. After 15 weeks of dietary treatment, the HFD mice were further assigned to HFD (n=10) or HFD plus HIT (HFD+HIT, n=10). The HFD+HIT mice were subjected to HIT during the last 8 weeks of the 23-week HFD course. HFD resulted in whole body insulin resistance, hypoadiponectinemia, suppressed expression of adiponectin receptor 1(AdipoR1) and 2 (AdipoR2), suppressed expression of phosphorylated AMP-activated protein kinase (p-AMPK) and NAD-dependent deacetylase sirtuin-1 (SIRT1), and decreased mRNAs of peroxisome proliferator-activated receptor-α (PPARα), carnitine palmitoyltransferase I (CPT1), and acyl CoA oxidase (ACO) in skeletal muscle. In contrast, HIT alleviated whole body insulin resistance and prevented decreased levels of total adiponectin in both serum and adipose tissue. HIT also prevented the down-regulation of AdipoR1 and AMPK/SIRT1 proteins and the down-regulation of PPARα, CPT1, and ACO mRNAs. The current findings show that HIT alleviates whole body insulin resistance due to HFD-induced obesity via the AdipoR1 and AMPK/SIRT1 mediated-signaling pathway in skeletal muscle, implying the potential role of HIT to combat this metabolic condition.

4.
Gene Ther ; 20(2): 143-50, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22402322

ABSTRACT

Medulloblastoma is a heterogeneous diffuse neoplasm that can be highly disseminated, and is the most common malignant childhood brain tumor. Although multimodal treatments have improved survival rates for patients with medulloblastoma, these tumors are associated with high morbidity and mortality. New treatment strategies are urgently needed to improve cure rates and, importantly, to spare normal brain tissue from neurotoxicity and patients from life-long cognitive and functional deficits associated with current therapies. In numerous preclinical brain tumor models, neural stem cells (NSCs) have shown great promise as delivery vehicles for therapeutic genes. Here, we have used an established, genetically modified human NSC line (HB1.F3.CD) to deliver carboxylesterase (CE) to cerebellar tumor foci and locally activate the prodrug camptothecin-11 (CPT-11) (Irinotecan) to the potent topoisomerase I inhibitor SN-38. HB1.F3.CD NSC tumor tropism, intratumoral distribution and therapeutic efficacy were investigated in clinically relevant experimental models. Magnetic resonance imaging was used for in vivo tracking of iron nanoparticle-labeled NSCs, and to assess the therapeutic efficacy of CE-expressing HB1.F3.CD cells. As compared with controls, a significant decrease in tumor growth rate was seen in mice that received both NSCs and CPT-11 as their treatment regimen. Thus, this study provides proof-of-concept for NSC-mediated CE/CPT-11 treatment of medulloblastoma, and serves as a foundation for further studies toward potential clinical application.


Subject(s)
Carboxylesterase/genetics , Cerebellar Neoplasms/therapy , Genetic Therapy , Medulloblastoma/therapy , Prodrugs/therapeutic use , Animals , Antineoplastic Agents, Phytogenic/therapeutic use , Camptothecin/analogs & derivatives , Camptothecin/therapeutic use , Cell Line, Tumor , Cerebellar Neoplasms/enzymology , Cerebellar Neoplasms/genetics , Gene Transfer Techniques , Humans , Irinotecan , Medulloblastoma/enzymology , Medulloblastoma/genetics , Mice , Mice, Nude , Mice, Transgenic , Neural Stem Cells/enzymology , Stem Cell Transplantation , Treatment Outcome
5.
Reprod Domest Anim ; 48(1): 90-7, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22594348

ABSTRACT

IZUMO1, belonging to the family of mammalian immunoglobulin proteins, has been well characterized in the mouse. Here, we describe the molecular cloning and expression analysis of porcine IZUMO1 (pIZUMO1). Partial sequence information published in the National Center for Biotechnology Information (NCBI) database was used to generate the full-length sequence for IZUMO1 using rapid amplification of cDNA ends (RACE). A search of the porcine genomic sequence in the NCBI database identified a bacterial artificial chromosome (BAC) encoding the pIZUMO1 gene. This BAC is derived from porcine chromosome 6 and is syntenic with the corresponding regions of mouse, bovine, and human genomes encoding the IZUMO gene family. This BAC was found to encode an IZUMO1 protein with a predicted amino acid sequence having high similarity with mouse and human IZUMO1. Western blot analysis of proteins from porcine tissues indicated that pIZUMO1 was specifically expressed in the sperm. Furthermore, to confirm whether pIZUMO1 forms complexes, we overexpressed pIZUMO1 in HEK293 cells. The recombinant pIZUMO1 from cell extracts was found to form complexes. Our finding suggests that pIZUMO1 forms homodimeric complex on the sperm membrane. Furthermore, an IVF inhibition assay with an antibody for the porcine IZUMO1 Ig-like domain showed that Ig-like domain effectively prevented pig sperm-egg interactions.


Subject(s)
Immunoglobulins/metabolism , Swine/metabolism , Animals , Cloning, Molecular , HEK293 Cells , Humans , Immunoglobulins/genetics , Multigene Family , RNA , Reverse Transcriptase Polymerase Chain Reaction
6.
Nat Genet ; 18(2): 150-4, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9462744

ABSTRACT

It is unclear how polyglutamine expansion is associated with the pathogenesis of Huntington disease (HD). Here, we provide evidence that polyglutamine expansion leads to the formation of large intracellular aggregates in vitro and in vivo. In vitro these huntingtin-containing aggregates disrupt normal cellular architecture and increase in frequency with polyglutamine length. Huntingtin truncated at nucleotide 1955, close to the caspase-3 cleavage site, forms perinuclear aggregates more readily than full-length huntingtin and increases the susceptibility of cells to death following apoptotic stimuli. Further truncation of huntingtin to nucleotide 436 results in both intranuclear and perinuclear aggregates. For a given protein size, increasing polyglutamine length is associated with increased cellular toxicity. Asymptomatic transgenic mice expressing full-length huntingtin with 138 polyglutamines form exclusively perinuclear aggregates in neurons. These data support the hypothesis that proteolytic cleavage of mutant huntingtin leads to the development of aggregates which compromise cell viability, and that their localization is influenced by protein length.


Subject(s)
Huntington Disease/genetics , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Nuclear Proteins/chemistry , Nuclear Proteins/metabolism , Peptides , Animals , Cell Aggregation , Cell Line , Cell Survival , Haplorhini , Humans , Huntingtin Protein , Mice , Mice, Transgenic , Nerve Tissue Proteins/biosynthesis , Neurons/cytology , Neurons/metabolism , Neurons/pathology , Nuclear Proteins/biosynthesis , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Transfection
7.
Reprod Domest Anim ; 47(5): 791-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22151574

ABSTRACT

Apoptosis is an important determinant of the normal development of pre-implantation embryos in vitro. Recently, endoplasmic reticulum (ER) stress-mediated apoptosis has been extensively investigated in a wide variety of diseases. Efficient functioning of the ER is essential for most cellular activities and survival. Tauroursodeoxycholic acid (TUDCA), an endogenous bile acid, has been reported to attenuate ER stress-mediated cell death by interrupting the classic pathways of apoptosis. Therefore, in this study, the anti-apoptotic effect of TUDCA on ER stress-induced apoptosis was examined in pre-implantation pig embryos. Also, tunicamycin was used to investigate the effects of ER stress on pig embryo development. After in vitro maturation and fertilization, presumptive pig embryos were cultured in NCSU-23 medium supplemented with TUDCA or TM for 6 days at 39 °C, 5% CO(2) in air. All data were analysed using one-way anova and Duncan's multiple range test in the statistical analysis system (SAS). In addition, we also determined the optimal TM and TUDCA concentrations. Samples were treated with TM at concentrations of 0, 1, 2 or 5 µm and with TUDCA at concentrations of 0, 100, 200 or 300 µm. When TM was used during in vitro culture, only 8.2% (8/97) of the embryos developed to the blastocyst stage when the treatment concentration was 1 µm compared with 27.4% (28/102) of the embryos in the control group (p < 0.05). In contrast, the frequency of blastocyst formation and the number of cells were higher when treated with 200 µm TUDCA compared with the control group (32.8% and 39.5 vs 22.2% and 35.6, p < 0.05). Moreover, the developmental rate to the blastocyst stage embryo in the group treated with TM and TUDCA was not significantly different from that of the control group (17.8%, 26/142 vs 24.9%, 36/145). Furthermore, the blastocyst cell number was enhanced (31.9 vs 36.9) and apoptosis reduced (TUNEL-positive nuclei number, 6.0 vs 3.2) by TUDCA treatment in pig embryos. In the real-time quantitative RT-PCR analysis, the expression of anti-apoptotic Bcl-XL gene was shown to be increased in the blastocyst stage because of TUDCA treatment, whereas expression of pro-apoptotic Bax was decreased. In addition, we also found that TUDCA decreased the rate of TM-induced apoptosis in the pre-implantation stage. Taken together, our results indicate that TUDCA improves the developmental competence of pig embryos by modulating ER stress-induced apoptosis during the pre-implantation stage.


Subject(s)
Apoptosis/drug effects , Embryonic Development/drug effects , Sus scrofa/embryology , Taurochenodeoxycholic Acid/pharmacology , Animals , Apoptosis/genetics , Blastocyst/cytology , Blastocyst/physiology , Cells, Cultured , Embryo Culture Techniques/veterinary , Endoplasmic Reticulum Stress/drug effects , Endoplasmic Reticulum Stress/physiology , Female , Fertilization in Vitro/veterinary , In Situ Nick-End Labeling , Oocytes/physiology , RNA, Messenger/analysis , Tunicamycin/pharmacology
9.
Reprod Domest Anim ; 45(5): e201-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-19788517

ABSTRACT

The sperm-mediated gene transfer method is applicable to transgenesis in many species that use spermatozoa for reproduction recently, which has been shown various results. In the current study, we show that transgenic porcine embryos can be efficiently produced by employing a simple transfection method that uses magnetic nanoparticles (MNPs). The complexes formed between plasmid DNA and MNPs were bounded on ejaculated boar spermatozoa at a higher efficiency compared to methods using DNA alone or lipofection. Using confocal microscopy, rhodamine fluorophore-labelled MNPs were detected on external surfaces of the spermatozoa membrane, which were bounded on zona pellucida of in vitro maturated oocyte during in vitro fertilization. Electron microscopy revealed that clusters of MNPs were detected in inside of plasma membrane and nucleus of the spermatozoa head. Additionally, we found that magnetofected boar spermatozoa could be fertilized with oocytes in vitro and that the resulting gene of green fluorescent protein was detected in fertilized eggs by genomic PCR analysis. Taken together, these results suggest that MNPs can be used to efficiently introduce a transgene into embryo via spermatozoa.


Subject(s)
DNA/administration & dosage , Magnetics , Nanoparticles , Spermatozoa/physiology , Swine/physiology , Transfection/veterinary , Animals , Female , Fertilization , Fertilization in Vitro , Gene Expression Regulation/physiology , Male , Oocytes/physiology , Transfection/methods
10.
Gene Ther ; 16(9): 1066-76, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19554035

ABSTRACT

Recent studies have reported that glial cell line-derived growth factor (GDNF) has neurotrophic effects on the central nervous system, and the neural stem cells (NSCs) engrafted in animal models of stroke survive and ameliorate the neurological deficits. In this study, a stable human NSC line overexpressing GDNF (F3.GDNF) was transplanted next to the intracerebral hemorrhage (ICH) lesion site and a possible therapeutic effect was investigated. F3.GDNF human NSC line was transplanted into the cortex overlying the striatal ICH lesion. ICH was induced in adult mice by the unilateral injection of bacterial collagenase into the striatum. The animals were evaluated for 8 weeks with rotarod and limb placement tests. Transplanted NSCs were detected by beta-gal immunostaining with double labeling of neurofilament, microtubule associated protein-2, glial fibrillary acidic protein or human nuclear matrix antigen (HuNuMA). F3.GDNF human NSCs produced a four times higher amount of GDNF over parental F3 cells in vitro, induced behavioral improvement in ICH mice after brain transplantation and two- to threefold increase in cell survival of transplanted NSCs at 2 and 8 weeks post-transplantation. In F3.GDNF-grafted ICH brain, a significant increase in the antiapoptotic protein and cell survival signal molecules, and a marked reduction in proapoptotic proteins were found as compared with control group. Brain transplantation of human NSCs overexpressing GDNF in ICH animals provided functional recovery in ICH animals, and survival and differentiation of grafted human NSCs. These results indicate that the F3.GDNF human NSCs should be of a great value as a cellular source for the cellular therapy in animal models of human neurological disorders including ICH.


Subject(s)
Cerebral Hemorrhage/therapy , Genetic Therapy/methods , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Neurons/transplantation , Stem Cell Transplantation/methods , Animals , Apoptosis , Brain Tissue Transplantation/methods , Cell Differentiation , Cerebral Hemorrhage/metabolism , Cerebral Hemorrhage/physiopathology , Genetic Vectors , Glial Cell Line-Derived Neurotrophic Factor/genetics , Graft Survival , Humans , Mice , Mice, Inbred ICR , Neurons/metabolism , Recovery of Function , Retroviridae/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods
11.
Gene Ther ; 16(10): 1234-44, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19626053

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is the most common adult onset motoneuron disease. The etiology and precise pathogenic mechanisms of the disease remain unknown, and there is no effective treatment. Vascular endothelial growth factor (VEGF) has recently been shown to exert direct neurotrophic and neuroprotective effects in animal models of ALS. Here we show that intrathecal transplantation of immortalized human neural stem cells (NSCs) overexpressing human VEGF gene (HB1.F3.VEGF) significantly delayed disease onset and prolonged the survival of the SOD1G93A mouse model of ALS. At 4 weeks, post-transplantation grafted cells were found within the gray matter of the spinal cord. Furthermore, transplanted F3.VEGF cells that express neuronal phenotype (MAP2+) were found in the anterior horn of the spinal cord gray matter indicating that the transplanted human NSCs migrated into the gray matter, took the correct structural position, integrated into the spinal cord anterior horn and differentiated into motoneurons. Intrathecal transplantation of F3.VEGF cells provides a neuroprotective effect in the diseased spinal cord by concomitant downregulation of proapoptotic proteins and upregulation of antiapoptotic proteins. Our results suggest that this treatment modality of intrathecal transplantation of human NSCs genetically modified to overexpress neurotrophic factor(s) might be of value in the treatment of ALS patients without significant adverse effects.


Subject(s)
Amyotrophic Lateral Sclerosis/therapy , Neurons/transplantation , Stem Cell Transplantation/methods , Vascular Endothelial Growth Factor A/biosynthesis , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Disease Models, Animal , Graft Survival , Humans , Injections, Spinal , Mice , Mice, Transgenic , Microscopy, Fluorescence , Motor Activity/physiology , Motor Neurons/metabolism , Neurons/metabolism , Spinal Cord/metabolism , Stem Cells/metabolism , Survival Analysis , Vascular Endothelial Growth Factor A/genetics
12.
J Cell Biol ; 73(1): 1-13, 1977 Apr.
Article in English | MEDLINE | ID: mdl-856827

ABSTRACT

Conjugates of ricin agglutinin and phytohemagglutinin with horseradish peroxidase (HRP) were used for a cytochemical study of internalization of their plasma membrane "receptors" in cultured isolated mouse dorsal root ganglion neurons. Labeling of cells with lectin-HRP was done at 4 degrees C, and internalization was performed at 37 degrees C in a culture medium free of lectin-HRP. 15-20 min after incubation at 37 degrees C, lectin-HRP receptor complexes were seen in vesicles or tubules located near the plasma membrane. After 1-3 h at 37 degrees C, lectin-HRP-receptor complexes accumulated in vesicles and tubules corresponding to acid phosphatase-rich vesicles and tubules (GERL) at the trans aspect of the Golgi apparatus. A few coated vesicles and probably some dense bodies contained HRP after 3-6 h of incubation at 37 degrees C. Soluble HRP was not endocytosed under the conditions of this experiment or when it was present in the incubation medium at 37 degrees C. Internalization of lectin-HRP-receptor conjugates was decreased or inhibited by mitochondrial respiration inhibitors but not by cytochalasin B or colchicine. These studies indicate that lectin-labeled plasma membrane moieties of neurons are endocytosed primarily in elements of GERL.


Subject(s)
Endocytosis , Lectins , Neurons/metabolism , Receptors, Drug/metabolism , Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology , Endocytosis/drug effects , Endoplasmic Reticulum/ultrastructure , Golgi Apparatus/ultrastructure , Neurons/ultrastructure , Organoids/metabolism
13.
J Cell Biol ; 44(1): 172-91, 1970 Jan.
Article in English | MEDLINE | ID: mdl-4901373

ABSTRACT

Correlative data are presented here on the developmental history, dynamics, histochemistry, and fine structure of intranuclear rodlets in chicken sympathetic neurons from in vivo material and long-term organized tissue cultures. The rodlets consist of bundles of approximately 70 +/- 10 A proteinaceous filaments closely associated with approximately 0.4-0.8 micro spheroidal, granulofibrillar (gf) bodies of a related nature. These bodies are already present in the developing embryo a week or more in advance of the rodlets. In early formative stages rodlets consist of small clusters of aligned filaments contiguous with the gf-bodies. As neuronal differentiation progresses these filaments increase in number and become organized into well-ordered polyhedral arrays. Time-lapse cinemicrography reveals transient changes in rodlet contour associated with intrinsic factors, changes in form and position of the nucleolus with respect to the rodlet, and activity of the gf-bodies. With the electron microscope filaments may be seen extending between the nucleolus, gf-bodies, and rodlets; nucleoli display circumscribed regions with fine structural features and staining reactions reminiscent of those of gf-bodies, We suggest that the latter may be derivatives of the nucleolus and that the two may act together in the assemblage and functional dynamics of the rodlet. The egress of rodlet filaments into the cytoplasm raises the possibility that these might represent a source of the cell's filamentous constituents.


Subject(s)
Cell Nucleus , Chickens , Ganglia, Autonomic/cytology , Animals , Cell Nucleolus , Chick Embryo , Culture Techniques , Histocytochemistry , Microscopy, Electron , Microscopy, Phase-Contrast , Motion Pictures , Time Factors
14.
Science ; 178(4067): 1298-300, 1972 Dec 22.
Article in English | MEDLINE | ID: mdl-4640069

ABSTRACT

Acetylcholinesterase activity in cultures of dissociated skeletal muscle prepared from the thigh muscle of the 10-day-old chick embryo was increased by the presence of innervating spinal cord explants, spinal cord explants in a parabiotic environment, and by media containing brain-spinal cord extract.


Subject(s)
Acetylcholinesterase/metabolism , Culture Techniques , Muscles/enzymology , Spinal Cord , Animals , Brain , Chick Embryo , Culture Media , Enzyme Activation , Muscles/cytology , Muscles/innervation , Neuromuscular Junction , Tissue Extracts
15.
Science ; 293(5536): 1820-4, 2001 Sep 07.
Article in English | MEDLINE | ID: mdl-11474066

ABSTRACT

Many central nervous system regions at all stages of life contain neural stem cells (NSCs). We explored how these disparate NSC pools might emerge. A traceable clone of human NSCs was implanted intraventricularly to allow its integration into cerebral germinal zones of Old World monkey fetuses. The NSCs distributed into two subpopulations: One contributed to corticogenesis by migrating along radial glia to temporally appropriate layers of the cortical plate and differentiating into lamina-appropriate neurons or glia; the other remained undifferentiated and contributed to a secondary germinal zone (the subventricular zone) with occasional members interspersed throughout brain parenchyma. An early neurogenetic program allocates the progeny of NSCs either immediately for organogenesis or to undifferentiated pools for later use in the "postdevelopmental" brain.


Subject(s)
Cell Movement , Neocortex/cytology , Neocortex/embryology , Neurons/cytology , Prosencephalon/cytology , Prosencephalon/embryology , Stem Cells/cytology , Animals , Brain Tissue Transplantation , Cell Differentiation , Cell Lineage , Cell Transplantation , Clone Cells/cytology , Clone Cells/transplantation , Humans , Macaca radiata/embryology , Neurons/transplantation , Stem Cell Transplantation , Transplantation, Heterologous
16.
Int J Sports Med ; 30(9): 677-83, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19569013

ABSTRACT

Little is known about whether lifestyle factors such as dietary intake, physical activity (PA), and cardio/respiratory fitness (CRF) are associated with metabolic risk factors in Korean children. The purpose of the study was to investigate the relationships among those lifestyle-related modifiable factors and the clustering of metabolic risk factors in young Korean children. In a cross-sectional study, we studied 246 Korean children (mean+/-SD; age: 12.6+/-0.5 years, BMI: 19.9+/-3.2 kg/m (2)) who were recruited from local elementary schools. In the total study population, physical activity and CRF were inversely associated with metabolic risk factors including body fatness, blood pressures, blood lipids and glucose. Daily caloric intake and proportion of carbohydrates were positively associated with BMI and percent body fat only. Multivariate regression analyses showed that physical activity was independently and inversely associated with the clustering of metabolic risk factors, even after adjustments for age, sex, sexual maturation, dietary intake, and CRF. Overall, the current findings of the study suggest that physical activity rather than CRF and/or dietary intake is an independent predictor for the clustering of metabolic risk factors in Korean children.


Subject(s)
Metabolic Syndrome/etiology , Motor Activity , Physical Fitness , Adolescent , Child , Cross-Sectional Studies , Dietary Carbohydrates , Energy Intake , Female , Humans , Korea , Life Style , Male , Metabolic Syndrome/physiopathology , Multivariate Analysis , Regression Analysis , Risk Factors
17.
Int J Sports Med ; 30(12): 892-7, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19885780

ABSTRACT

Unlike in Europeans and Africans, the relationship between the human guanine nucleotide binding beta polypeptide 3 (GNB3) C825T gene polymorphism (rs5443) and blood pressures is inconsistent in Asians. The aim of the study was to investigate whether the GNB3 genotype demonstrates different associations with resting blood pressure and body fatness across cardio/respiratory fitness (CRF) levels. A total of 727 Korean women aged 31-60 years (mean, 47.8+/-5.4 years) participated in the study. In subgroup analyses of the obese group, TT individuals had significantly higher values of body weight than CC and CT individuals (p=0.006 and p=0.006, respectively) and body mass index (BMI) (p=0.002 and p=0.011, respectively). TT and CT individuals also tended to have higher CRF values than CC individuals. Regression analyses showed that the association between GNB3 genotype and resting blood pressure remained significant after adjustment for age and menopause, but was not significant after additional adjustment for body fatness. In summary, the findings of this study suggest that body fatness and CRF might modify the GNB3-mediated genetic susceptibility to elevated resting blood pressures in middle-aged Korean women.


Subject(s)
Adiposity/genetics , Blood Pressure/genetics , Heterotrimeric GTP-Binding Proteins/genetics , Polymorphism, Genetic , Adult , Asian People/genetics , Body Mass Index , Body Weight/genetics , Female , Genetic Predisposition to Disease , Humans , Hypertension/genetics , Korea , Middle Aged , Obesity/genetics , Regression Analysis
18.
AJNR Am J Neuroradiol ; 40(6): 946-953, 2019 06.
Article in English | MEDLINE | ID: mdl-31097431

ABSTRACT

BACKGROUND AND PURPOSE: Assessment of the collateral status has been emphasized for appropriate treatment decisions in patients with acute ischemic stroke. The purpose of this study was to introduce a multiphase MRA collateral imaging method (collateral map) derived from time-resolved dynamic contrast-enhanced MRA and to verify the value of the multiphase MRA collateral map in acute ischemic stroke by comparing it with the multiphase collateral imaging method (MRP collateral map) derived from dynamic susceptibility contrast-enhanced MR perfusion. MATERIALS AND METHODS: From a prospectively maintained registry of acute ischemic stroke, MR imaging data of patients with acute ischemic stroke caused by steno-occlusive lesions of the unilateral ICA and/or the M1 segment of the MCA were analyzed. We generated collateral maps using dynamic signals from dynamic contrast-enhanced MRA and DSC-MRP using a Matlab-based in-house program and graded the collateral scores of the multiphase MRA collateral map and the MRP collateral map independently. Interobserver reliabilities and intermethod agreement between both collateral maps for collateral grading were tested. RESULTS: Seventy-one paired multiphase MRA and MRP collateral maps from 67 patients were analyzed. The interobserver reliabilities for collateral grading using multiphase MRA or MRP collateral maps were excellent (weighted κ = 0.964 and 0.956, respectively). The agreement between both collateral maps was also excellent (weighted κ = 0.884; 95% confidence interval, 0.819-0.949). CONCLUSIONS: We demonstrated that the dynamic signals of dynamic contrast-enhanced MRA could be used to generate multiphase collateral images and showed the possibility of the multiphase MRA collateral map as a useful collateral imaging method in acute ischemic stroke.


Subject(s)
Collateral Circulation , Magnetic Resonance Angiography/methods , Neuroimaging/methods , Stroke/diagnostic imaging , Aged , Brain Ischemia/diagnostic imaging , Female , Humans , Male , Middle Aged , Pilot Projects
19.
Acta Neurol Scand ; 118(1): 60-7, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18261165

ABSTRACT

OBJECTIVES: To study the involvement of cystatin C in the progression of ischemic white matter lesions (WMLs). MATERIALS AND METHODS: Cystatin C levels in the cerebrospinal fluid (CSF) of patients with cerebrovascular disease, and also in primary and established human neural cell cultures were investigated. For pathologic analysis, cystatin C immunoreactivity was investigated in the white matter of patients with severe WMLs, mild WMLs or controls. RESULTS: Cystatin C levels in the CSF of patients with Fazekas WML grade 3 [14 with hypertension; W/HT(+) and nine without hypertension; W/HT(-)] were lower than those in 38 patients with grade 0-1 (P = 0.0022 and P < 0.0001 respectively). Immunohistochemical study showed that the cystatin C immunoreactivity was found in astrocytes, and the number of astrocytes in the white matter in the severe WML group was decreased when compared with that in controls (P = 0.0027) and in the mild WML group (P = 0.0024). In human neural cell cultures, treatments with thrombin, matrix metalloproteinases and interleukin 1 beta increased the expression of cystatin C mRNA in human astrocytes and hybrid neurons, but an enzyme-linked immunosorbent assay revealed that only thrombin significantly increased the production and secretion of cystatin C in astrocytes. CONCLUSIONS: These results suggest that low levels of CSF cystatin C in ischemic WMLs might be due to the decreased number of astrocytes that secrete cystatin C in response to the stimuli of proteases and inflammatory cytokines.


Subject(s)
Brain Ischemia/metabolism , Brain Ischemia/pathology , Cystatins/metabolism , Aged , Aged, 80 and over , Astrocytes/metabolism , Brain Ischemia/etiology , Case-Control Studies , Cell Culture Techniques , Cystatin C , Diabetes Complications/complications , Diabetes Complications/metabolism , Diabetes Complications/pathology , Female , Humans , Hypertension/complications , Hypertension/metabolism , Hypertension/pathology , Male , Middle Aged , Neurons/metabolism
20.
Aliment Pharmacol Ther ; 48(3): 300-312, 2018 08.
Article in English | MEDLINE | ID: mdl-29920701

ABSTRACT

BACKGROUND: Sarcopenia is significantly associated with the degree of liver fibrosis. This study investigated the influence of sarcopenia on liver fibrosis in individuals with chronic hepatitis B. METHODS: Data from the Korean National Health and Nutrition Examination Surveys 2008-2011 were analysed. The sarcopenia index (total appendicular skeletal muscle mass [kg]/body mass index [kg/m2 ]) was calculated using dual-energy X-ray absorptiometry. Sarcopenia was defined as the lowest quintile sarcopenia index value (cut-offs: 0.89 for men and 0.58 for women). The fibrotic burden was assessed using the nonalcoholic fatty liver disease fibrosis score and fibrosis-4 index. Significant fibrosis was defined as the highest nonalcoholic fatty liver disease fibrosis score quartile and a fibrosis-4 index ≥2.67. RESULTS: Among the 506 respondents with chronic hepatitis B (258 men and 248 women), the nonalcoholic fatty liver disease fibrosis score and fibrosis-4 index identified sarcopenia and significant fibrosis in 126 (24.9%) and 217 (42.9%), respectively. Sarcopenia was significantly associated with significant fibrosis, regardless of the fibrosis prediction model used (all P < 0.05). When the study population was stratified according to metabolic factors, sarcopenia was specifically associated with an increased risk of significant fibrosis among subgroups with obesity, insulin resistance, metabolic syndrome and liver steatosis (odds ratio 2.37-3.57; all P < 0.05). An independent association between sarcopenia and significant fibrosis was identified after adjusting for other confounders (odds ratio 2.67-3.62 by the nonalcoholic fatty liver disease fibrosis score and 2.04-2.62 by the fibrosis-4 index; all P < 0.05). CONCLUSIONS: Sarcopenia is associated with significant fibrosis in subjects with chronic hepatitis B, specifically those with obesity, insulin resistance, metabolic syndrome and liver steatosis.


Subject(s)
Hepatitis B, Chronic/epidemiology , Liver Cirrhosis/epidemiology , Metabolic Diseases/epidemiology , Sarcopenia/epidemiology , Absorptiometry, Photon , Adult , Aged , Body Mass Index , Cross-Sectional Studies , Female , Hepatitis B, Chronic/complications , Humans , Insulin Resistance , Liver Cirrhosis/complications , Male , Metabolic Diseases/complications , Metabolic Syndrome/complications , Metabolic Syndrome/epidemiology , Middle Aged , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/epidemiology , Nutrition Surveys , Obesity/complications , Obesity/epidemiology , Republic of Korea/epidemiology , Risk Factors , Sarcopenia/complications , Sarcopenia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL